Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Clinical trial NCT02243358 · COMPLETED

Trial details

NCT number: NCT02243358
Sponsor: Henry Ford Health System
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreas Neoplasm Malignant Resectable

Start date: 2014-02-01
Primary completion: 2017-06-28
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.